These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 28668085

  • 1. Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy.
    Clerici AM, Nobile-Orazio E, Mauri M, Squellati FS, Bono GG.
    BMC Neurol; 2017 Jul 01; 17(1):127. PubMed ID: 28668085
    [Abstract] [Full Text] [Related]

  • 2. Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.
    Cirillo G, Todisco V, Tedeschi G.
    Clin Neurophysiol; 2018 May 01; 129(5):967-973. PubMed ID: 29554579
    [Abstract] [Full Text] [Related]

  • 3. Chronic immune sensory polyradiculopathy (CISP): First juvenile case description.
    Sotgiu S, Minutolo A, Carta A, Puseddu G, Doneddu PE, Nobile-Orazio E.
    Neurol Sci; 2021 Jan 01; 42(1):333-336. PubMed ID: 32651857
    [Abstract] [Full Text] [Related]

  • 4. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.
    Hughes R, Dalakas MC, Merkies I, Latov N, Léger JM, Nobile-Orazio E, Sobue G, Genge A, Cornblath D, Merschhemke M, Ervin CM, Agoropoulou C, Hartung HP, FORCIDP Trial Investigators.
    Lancet Neurol; 2018 Aug 01; 17(8):689-698. PubMed ID: 30001923
    [Abstract] [Full Text] [Related]

  • 5. Chronic immune polyradiculopathies: Three clinical variants of one disease?
    Khadilkar SV, Patel R, Shah N, Deshmukh ND, Patel BA, Mansukhani KA.
    Muscle Nerve; 2021 Jan 01; 63(1):99-103. PubMed ID: 32710692
    [Abstract] [Full Text] [Related]

  • 6. Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy.
    Yiannikas C, Vucic S.
    Muscle Nerve; 2008 Nov 01; 38(5):1447-1454. PubMed ID: 18932207
    [Abstract] [Full Text] [Related]

  • 7. Chronic immune sensory polyradiculopathy (CISP).
    Ong S, Cassidy A.
    Pract Neurol; 2022 Feb 01; 22(1):57-59. PubMed ID: 34740963
    [Abstract] [Full Text] [Related]

  • 8. Economic Evaluation of Intravenous Immunoglobulin plus Corticosteroids for the Treatment of Steroid-Resistant Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Thailand.
    Bamrungsawad N, Upakdee N, Pratoomsoot C, Sruamsiri R, Dilokthornsakul P, Dechanont S, Wu DB, Dejthevaporn C, Chaiyakunapruk N.
    Clin Drug Investig; 2016 Jul 01; 36(7):557-66. PubMed ID: 27113227
    [Abstract] [Full Text] [Related]

  • 9. Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases.
    Larue S, Bombelli F, Viala K, Neil J, Maisonobe T, Bouche P, Musset L, Fournier E, Léger JM.
    Eur J Neurol; 2011 Jun 01; 18(6):899-905. PubMed ID: 21199182
    [Abstract] [Full Text] [Related]

  • 10. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J.
    Acta Neurol Scand; 2005 Aug 01; 112(2):115-25. PubMed ID: 16008538
    [Abstract] [Full Text] [Related]

  • 11. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression.
    Hung SKY, Hiew FL, Viswanathan S, Puvanarajah S.
    J Peripher Nerv Syst; 2018 Sep 01; 23(3):183-189. PubMed ID: 30027593
    [Abstract] [Full Text] [Related]

  • 12. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia.
    Sinnreich M, Klein CJ, Daube JR, Engelstad J, Spinner RJ, Dyck PJ.
    Neurology; 2004 Nov 09; 63(9):1662-9. PubMed ID: 15534252
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic utility of somatosensory evoked potentials in chronic polyradiculopathy without electrodiagnostic signs of peripheral demyelination.
    Devic P, Petiot P, Mauguiere F.
    Muscle Nerve; 2016 Jan 09; 53(1):78-83. PubMed ID: 25908550
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of intravenous immunoglobulin in CIDP.
    Vucic S, Black K, Baldassari LE, Tick Chong PS, Dawson KT, Cros D.
    Clin Neurophysiol; 2007 Sep 09; 118(9):1980-4. PubMed ID: 17604689
    [Abstract] [Full Text] [Related]

  • 15. Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Shije J, Brannagan TH.
    Semin Neurol; 2019 Oct 09; 39(5):596-607. PubMed ID: 31639843
    [Abstract] [Full Text] [Related]

  • 16. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Eftimov F, Winer JB, Vermeulen M, de Haan R, van Schaik IN.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD001797. PubMed ID: 19160200
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R, Sockalingam S, Shahrizaila N, Cheah TE, Zain AA, Goh KJ.
    Lupus; 2012 Sep 21; 21(10):1119-23. PubMed ID: 22433918
    [Abstract] [Full Text] [Related]

  • 18. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S, Isose S, Mori M, Mitsuma S, Sawai S, Beppu M, Sekiguchi Y, Misawa S.
    J Neurol Neurosurg Psychiatry; 2015 Oct 21; 86(10):1054-9. PubMed ID: 25424435
    [Abstract] [Full Text] [Related]

  • 19. Treatment of chronic inflammatory demyelinating polyneuropathy.
    Kleyman I, Brannagan TH.
    Curr Neurol Neurosci Rep; 2015 Jul 21; 15(7):47. PubMed ID: 26008811
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy.
    Kaplan A, Brannagan TH.
    Muscle Nerve; 2017 Apr 21; 55(4):476-482. PubMed ID: 27463215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.